OBJECTIVE: The aim of this study was to look for a relationship between autonomic dysfunction and alterations in glucose-induced thermogenesis (GIT) and lipid oxidation rate in obese non-diabetic women. SUBJECTS: 37 obese women, 20 with impaired cardiac autonomic function tests (group 1) were matched with 17 women with normal tests (group 2) according to age, weight, body mass index (BMI), waist-to-hip ratio (WHR), fat mass (FM) and fat free mass (FFM). MEASUREMENTS: A series of ®ve standardized tests was carried out, three of which were based mainly on cardiac parasympathetic control (heart rate response to Valsalva, deep breathing and lying-to-standing) and two on cardiovascular sympathetic function (blood pressure response to standing and to handgrip). Energy expenditure (EE), lipid and glucose oxidation rate were determined by indirect calorimetry at fasting and after an oral glucose load (75 g). Blood glucose, insulin and catecholamines responses to glucose were examined. RESULTS: There was no signi®cant difference in plasma glucose, insulin, catecholamines, metabolic rate, glucose and lipid oxidation rate at fasting and plasma glucose, insulin and catecholamine responses to glucose. GIT was slightly but not signi®cantly lower in group 1 (24.7 AE 10.4 kJ) than in group 2 (46.8 AE 9.0 kJ). The cumulative glucose oxidation rate did not differ signi®cantly in the two groups. The cumulative lipid oxidation rate was signi®cantly lower in group 1 than in group 2 (749.4 AE 4.1 vs 730.8 AE 8.0, respectively, P 0.033). It correlated negatively with the area under the curve of insulin response (r 70.37, P 0.04). In the multivariate analysis, both autonomic dysfunction and the area under the curve of insulin response correlated signi®cantly with the cumulative lipid oxidation rate. CONCLUSION: This study suggests that 1) the glucose-induced inhibition of the lipid oxidation rate in obese women is greater in the patients with autonomic dysfunction; 2) a decrease in sympathetic activity is likely to be involved in this phenomenon.
Introduction
Alterations in heart rate variability are a well known complication of diabetes mellitus. 1, 2 Such alterations are also found in non-diabetic obese patients and suggest a parasympathetic dysfunction. 3, 4 In these patients, a reduction in peripheral vasoconstrictive response to sympathetic stimuli is also found 5 and might be indicative of a sympathetic disorder consisting of a defect in sympathetic nerve activation or in peripheral adrenoreceptors.
Resting metabolic rate (RMR) is in¯uenced (independently of body composition and physical activity) by fat free mass (FFM), gender 6 ± 8 and overfeeding. 9 It is slightly in¯uenced by the phase of menstrual cycle in women 10 and apparently not by the type of obesity. 11, 12 An impairment of glucose-induced thermogenesis (GIT) or diet-induced thermogenesis in obese patients has been reported by several investigators. 13 ± 15 However, data in obesity are controversial inasmuch as post-prandial thermogenesis has also been found to be the same in obese and lean subjects. 16, 17 More recently a decrease in GIT has been found early after the onset of obesity, which supports the hypothesis of a possible involvement of this defect in the genesis of obesity. 18 Diet-induced thermogenesis depends on several factors, on the type of obesity to some extent, 11 on the phase of the menstrual cycle 10 and most interestingly, on regulation by insulin and sympathetic nervous activity. Indeed activation of the sympathetic nervous system, as shown by muscle nerve sympathetic activity, 19, 20 and an increase in plasma catecholamine concentration and in cardiac sympatho-excitation, 21±23 occurs after a standard meal or an oral glucose load. The role played by sympathetic activation is supported by the reduction in GIT induced by a beta-blocking agent. 24, 25 Insulin response to a meal or glucose intake, is probably at least partially involved in sympathetic activation 26, 27 even if this point remains to be evaluated precisely.
The role of insulin is suggested by the restitution of a normal sympathetic response to oral glucose load in insulin-dependent diabetic patients with neuropathy after insulin administration. 28 It may therefore be hypothesized that a reduction in GIT in obese patients might be related to a decrease in sympathetic activation. Whether there is a link between thermogenesis and autonomic disorders is unknown. Nevertheless, a reduction in both heart rate variability and GIT has been reported in diabetic and obese patients, 29 suggesting a relationship between autonomic dysfunction and thermogenesis.
Since we have found a parasympathetic cardiac dysfunction in nearly 50% of non-diabetic obese patients, 3 the aim of the present study was to investigate autonomic activity more precisely and the potential in¯uence of autonomic dysfunction in GIT and lipid oxidation in obese women.
Patients and methods

Patients
Thirty-seven women, aged 16 ±58 y were recruited for the study. All had a body mass index (BMI)b27 kgam 2 . None of them was diabetic or had hepatic or renal disorders. None had cardiovascular disease, hypertension, lung disease or anaemia, or was taking drugs that can change the cardiovascular autonomic function tests, and none had symptoms of autonomic neuropathy or peripheral neuropathy. The standard 12-lead electrocardiogram was normal.
The investigations were performed before the beginning of our weight-loss program; no such program had been carried out within the three months prior to this study.
Methods
Experimental design. Energy expenditure (EE) was measured by indirect calorimetry, under carefully standardized conditions. The subjects were asked to refrain from smoking and drinking alcohol at least 12 h before the test procedure. The night before the investigation, they slept in our metabolic unit, where ambient temperature was between 22±24 C in order to ensure basal conditions. They fasted overnight and after voiding, remained in a semirecumbent position until the measurements were completed in the metabolic unit. A venous catheter was inserted into an antecubital vein for blood sampling and the line was kept patent with physiological saline.
Continuous respiratory measurements were begun at 07.30 h, one hour before oral intake of glucose, and maintained over the next three hours. After one hour of bed rest and basal calorimetry measurements, an oral glucose load of 75 g was administered in 300 ml water, within 5 min. Blood samples were withdrawn at 720 min, and from 0 ±180 min at 30 min intervals, for glucose, insulin, adrenaline and noradrenaline determinations. Urine was collected during the night (22.00 ± 07.30 h) and again at the end of the calorimetric measurements. The urine volume was measured and the glucose and nitrogen contents were determined.
Respiratory exchange measurements. Indirect calorimetry measurements were performed by using a continuous open-circuit ventilated-hood system (Deltatrac Monitor MBM-100, Datex Instrumentarium Corp., Helsinki, Finland). A calibration of oxygen, carbon dioxide and air¯ow was carried out with reference gas before the beginning of the test. The oxygen and CO 2 concentrations were continuously measured, with the mean values of CO 2 production and O 2 consumption calculated for each 1 min interval. Glucose, lipid and protein oxidation rates and energy expenditure were determined according to Ferrannini. 30 Basal measurements were averaged over the last 30 min of the preload resting period. Post-glucose load measurements: EE, glucose and lipid oxidation rates were averaged over the 180 min period after glucose intake, at 30 min intervals. GIT was calculated over the 3 h after glucose intake as the incremental (compared with baseline) area under the EE curve. Similarly, cumulative glucose and lipid oxidation rates over the 3 h were calculated as the area under the curves compared with basal levels.
It must be noted that none of the patients had glycosuria during the test.
Body composition. FFM and fat mass (FM) were measured by bioelectrical impedance analysis (BIA), using a portable two-electrode impedance device (IMP B01; l'Impulsion, Caen, France). 31 Cardiovascular autonomic function tests. Five standardized tests were carried out on all the subjects within 24 h after admission to the hospital, as previously described.
1±3
Three of these tests were used to investigate mainly cardiac parasympathetic control. We previously demonstrated the fairly good reproducibility of these three tests. 32 The results based on the assessment of heart rate variations were obtained by computerized analysis using the Autocaft system 33 
:
The Valsalva manoeuvre was carried out with the subjects seated. They were asked to exhale a deep breath in order to maintain 40 mmHg pressure for 15 s. The result was expressed as the Valsalva ratio (RR (interval between two consecutive R waves on ECG recording) maximum after breathing out, over the RR minimum while breathing out). The value recorded corresponded to the mean value for three consecutive Valsalva tests. For the deep-breathing test, the subjects were asked to take six deep breaths in one minute in a recumbent Lipid oxidation in obese women P Valensi et al position, after practising. The result was expressed as the mean value for the ratio of the maximum (while breathing out) over the minimum (while breathing in) RR interval during the six deep breaths. For the lying-to-standing test, the patients were asked to remain lying for one minute and then stand up quickly. The result was expressed as the ratio between maximum (about the 30th s after standing up) over the minimum (about the 15th s after standing up) RR interval.
The results of these tests were compared with a previously published control group investigated with the same device, after taking age into account. 34 The other two tests were used to investigate sympathetic cardiovascular control:
Blood pressure response to the lying-to-standing test was measured after 10 min with the patient in a supine position and again one minute after standing up. Orthostatic hypotension was de®ned as a drop in systolic pressure of at least 20 mmHg. A handgrip test was also performed. This involved measuring maximum isometric handgrip on a dynamometer, and then maintaining 30% of this maximum grip for 5 min, with blood pressure measured every minute with a semi-automatic blood pressure recorder (Dinamap, Critikon, Tampa, FL, USA). This test was considered to be abnormal if the elevation in diastolic blood pressure was below 10 mmHg.
A parasympathetic dysfunction was considered to be moderate if one of the three parasympathetic tests was abnormal, con®rmed if two of these tests were abnormal and severe if the three tests were abnormal. Sympathetic dysfunction was considered to be present if either postural hypotension or an abnormal response to the handgrip test was found.
Analytical procedures. Plasma glucose determination was performed at the routine laboratory using the hexokinase method. Serum fructosamine was measured by a colorimetric method using tetrazolium blue (Roche Diagnostic System, NeuillyaSeine, France) and HbA 1c by microcolumn chromatography.
The urine nitrogen content was determined by chemiluminescence. 35 Serum insulin was measured by radioimmunoassay (Behring, Mahrburg, Germany) with mean inter-and intra-assay coef®cients of variation of less than 10%. Plasma adrenaline and noradrenaline were assayed by high performance liquid chromatography with electrochemical detection, the coef®cients of variation being 9% and 3%, respectively.
The areas under the curves of insulin and catecholamine responses were calculated.
Statistical analyses.
Results are shown as means AE s.e.m. Comparisons between groups were performed by one-way analysis of variance or MannWhitney tests according to the gaussian or non-gaussian distribution of the data. Linear correlations between two sets of normally distributed quantitative parameters were calculated. Multivariate analysis was performed according to a stepwise regression model (forward analysis).
Statistical analyses were performed with the SPSS package on a PC device.
Results
Cardiac autonomic function tests
In 20 of the 37 patients, at least one of the three parasympathetic tests was abnormal and in ®ve of these patients one or both sympathetic tests were abnormal. These 20 patients were considered to have autonomic dysfunction (Group 1). Table 1 compares the physical characteristics of all the patients in Group 1 with the 17 patients with normal autonomic tests (Group 2). In the two groups mean age, weight, body mass index (BMI), waist to hip ratio (WHR), FFM, FM and blood pressure were very similar. HbA 1c and serum fructosamine were normal in all the patients (`6.25% and`285 mmolal, respectively). Fasting plasma glucose, serum fructosamine, plasma insulin, adrenaline and noradrenaline did not differ signi®cantly between the two groups ( Table 2) .
Calorimetric measurements at fasting
The RMR was very similar in both groups (Table 3 ). In the entire series of 37 patients, RMR signi®cantly correlated with FFM (r 0.63, P`0.0001) and FM (r 0.42, P 0.022). Glucose and lipid oxidation rates were not signi®cantly different between the two groups.
Blood glucose and hormonal course after the glucose oral load
According to the responses to the glucose oral load, none of the patients met the criteria for diabetes mellitus or glucose intolerance. The plasma glucose and insulin responses were very similar in the two Lipid oxidation in obese women P Valensi et al groups ( Table 2 ). The areas under the curves of catecholamine responses did not differ signi®cantly in the two groups. There was no signi®cant correlation between the areas under the curves of the catecholamine and insulin responses.
Calorimetric measurements after glucose load
GIT was slightly, but not signi®cantly, lower in Group 1 than in Group 2 (Table 3) . In all 37 patients, it correlated signi®cantly with the WHR (r 0.37, P 0.026). It did not correlate with fasting plasma insulin or catecholamine, or with the areas under the curves of the insulin or catecholamine responses. The cumulative glucose oxidation rate (area under the curve over 3 h) was not signi®cantly different between the two groups. The cumulative lipid oxidation rate (area under the curve) was signi®cantly lower in Group 1 than in Group 2 (P 0.033) ( Table 3) . It was correlated negatively with the area under the curve of insulin response (r 70.370, P 0.04).
A multivariate analysis was performed, with the cumulative lipid oxidation rate entered as dependent variable and the area under the curve of insulin response and cardiac autonomic dysfunction (present or absent) as independent variables. Both these variables signi®cantly correlated with the cumulative lipid oxidation rate (Table 4) .
Discussion
Glucose-induced thermogenesis involves two components: the obligatory one and the facultative one which mainly depends on sympathetic nervous activity, since it can be partially inhibited by the infusion of a beta-blocking agent, propranolol. 24, 25 An alteration in the sympathetic nervous system could help to explain the glucose-or diet-induced thermogenesis defect in obese subjects. Very few data are available in the literature concerning the possible relationship between an autonomic disorder and the reduction in thermogenesis. In the present work, cardiovascular autonomic dysfunction was carefully looked for by standardized and reproducible tests. We detected a cardiac parasympathetic dysfunction in several obese women, some of whom also had sympathetic dysfunction.
The RMR was very similar in the obese patients with and without autonomic dysfunction, but there was a trend to a lower GIT in the patients with autonomic dysfunction. A signi®cant difference between the two groups might have been found if Table 2 Plasma glucose, insulin, and catecholamine at baseline and after glucose oral load in obese subjects with autonomic dysfunction (Group 1) and with normal autonomic tests (Group 2)
Group1
Group 2 n 20 n 17 A area under the curve determined over 3 h.
Lipid oxidation in obese women P Valensi et al the GIT had been measured for up to 4 h or more after glucose load. 22 However, the present data are in agreement with the results of Golay et al 29 who found a signi®cant positive correlation between heart rate variability and glucose-induced thermogenesis and who evoked the possible role of the parasympathetic nervous system in glucose-induced thermogenesis, which to our knowledge has never been con®rmed. 29 However heart rate variability was studied according to variations at 30 s intervals, which depend probably on both parasympathetic and sympathetic control, but also on some long-term regulatory factors, as has been shown by spectral analysis studies of heart rate and blood pressure variations. 36, 37 In the present study, glucose-induced thermogenesis correlated positively with the WHR as previously reported by Van Gaal et al 11 who suggested that hyperinsulinaemia associated with upper body (android) obesity might participate in the increase in GIT. However we did not ®nd any correlation between WHR and fasting insulin concentration or with insulin response.
The cumulative lipid oxidation rate correlated negatively with insulin response to the glucose oral load, as expected. It was also signi®cantly lower in the patients with autonomic dysfunction than in those with normal autonomic tests. The association between lipid oxidation rates after glucose load and the presence, or absence, of autonomic dysfunction, remained signi®cant in the multivariate analysis. The catecholamine response to glucose did not differ signi®cantly in the two groups. This does not rule out a difference in the catecholamine response for 4 h or more after glucose intake, since the adrenaline response has been shown to still be of importance 4 h after glucose ingestion. 22 Nor can a defect in tissue activation by catecholamines, possibly resulting from a defect in adrenoceptors, be excluded in the patients with autonomic dysfunction.
The strongest inhibition of lipid oxidation after glucose, in the patients with autonomic dysfunction, might therefore result from a lower glucose-induced sympathetic activation in these patients. In the obese subjects, muscle nerve sympathetic activity has been shown to be increased in the basal state 38Y 39 and, after glucose, either increased as much as 40 or less than 39 in the lean subjects, while insulin response to glucose was higher in the obese subjects. 39, 40 The lack of the expected increase in sympathetic activation, secondary to the higher insulin response, 26, 27 is consistent with the effects of insulin resistance on the sympathetic nervous system. Such a defect in sympathetic activation, might be the case in our patients. Indeed, all had parasympathetic dysfunction according to cardiac standardized tests. Some of them also had abnormal sympathetic tests, however, some recently proposed tests appear more sensitive than the tests we used here to detect a decrease in sympathetic activity. 5, 36, 37, 41 In particular, changes in parasympathetic and sympathetic heart control, evaluated by spectral analysis of heart rate variations, may occur in the same way and magnitude in obese and diabetic patients. 4, 36, 42 Moreover we have shown that the heart rate and blood pressure responses to sympathetic activation, induced by a handgrip, is reduced in the obese patients with a parasympathetic dysfunction. 43 The peripheral vasoconstrictive response to sympathetic activation also appears reduced in these patients. 5 Since insulin response to glucose in both its cephalic phase and post-absorptive phase is likely to play an important part in sympathetic nervous activation 26, 27 we may hypothesize that insulin response would be unable to stimulate the sympathetic nervous system normally in the patients with autonomic dysfunction. This phenomenon would appear to be one of the features of the insulin resistance syndrome.
Conclusion
The present study failed to demonstrate a signi®cant relationship between a reduction in autonomic activity and a reduction in glucose-induced thermogenesis in the obese patients. The main data concerns an association between autonomic dysfunction and changes in the substrate oxidation rates after glucose intake. The inhibition of lipid oxidation, in particular, was stronger in patients with autonomic dysfunction tests than in those with normal autonomic tests. While this might be an indirect association, the stronger lipid oxidation inhibition might actually be due to lower sympathetic activation. This result is consistent with the important pathophysiological role played by autonomic nervous system dysfunction in adipogenesis.
